We are so excited to announce that ARU under the direction of Dr. Hodis received funds from NHI for the clinical trial APPT (Advancing Postmenopausal Preventive Therapy). The goal of the project is to conduct a double-blinded, placebo-controlled trial to determine the effects of tissue selective estrogen complex (TSEC) therapy on the progression of subclinical atherosclerosis in healthy postmenopausal [...]
We here at ARU are very pleased to share the findings of the primary trial ELITE which was published on March 31, 2016 in the New England Journal of Medicine. In summary, in ELITE (Early versus Late Intervention Trial with Estradiol) trial, we examined the effects of estradiol on atherosclerosis in women who were within 6 [...]
Did you know that just 30 minutes of brisk walking five days a week can reduce risk of death from cardiovascular diseases? This is true especially for women younger than 70 years of age, says a new Argentinean study presented by Dr. Rosana Poggio, a cardiologist at the Institute for Clinical Effectiveness and Health Policy (IECS) in Buenos Aires, [...]
Dr. Hodis presented at the Scientific Session of American Heart Association, Chicago, “Testing the Menopausal Hormone Therapy Timing Hypothesis: the Early versus Late Intervention Trial with Estradiol”. The American Heart Association scientific program is aimed to communicate the advances from prevention to treatment for cardiovascular disease. Moreover, the sessions bring leaders in cardiovascular disease from all over the world. [...]
